Table 2 Characteristics of HIV-related services in buprenorphine treatment reported as mean (standard deviation) or percentage (count)
From: A mixed methods study of HIV-related services in buprenorphine treatment
| Â | Mean (SD) or % (N) | 95% CI | N |
|---|---|---|---|
Intake practicesa | |||
 All new patients are asked about frequency of injection drug use | 92.4% (1055) | 90.8–93.9 | 1142 |
 All new patients are asked about sharing of syringes | 82.9% (944) | 80.7–85.1 | 1139 |
 All new patients are asked about sharing of non-syringe drug paraphernalia (e.g., straws, cottons, cookers) | 53.2% (604) | 50.3–56.1 | 1136 |
 All new patients are asked about number of sexual partners | 48.0% (548) | 45.1–50.9 | 1141 |
 All new patients are asked about frequency of unprotected sexual intercourse | 48.5% (554) | 45.6–51.4 | 1142 |
 Count of intake practices | 3.2 (1.6) | 3.1–3.3 | 1127 |
HIV education | |||
 Physician delivers HIV/AIDS education to his/her patientsa | 62.0% (709) | 59.2–64.8 | 1144 |
 Patient education emphasis on how HIV/AIDS is transmittedb | 2.0 (1.9) | 1.9–2.2 | 1136 |
 Patient education emphasis on the importance of not sharing syringesb | 2.5 (2.2) | 2.4–2.6 | 1137 |
 Patient education emphasis on the importance of not sharing other drug paraphernaliab | 2.1 (2.1) | 1.9–2.2 | 1136 |
 Patient education emphasis on development of safer sex practicesb | 2.1 (2.0) | 2.0–2.2 | 1132 |
 Patient education emphasis on skill rehearsal of correct condom useb | 0.7 (1.4) | 0.7–0.8 | 1335 |
 Patient education emphasis on practicing partner communication and negotiation skills about safer sex practicesb | 1.0 (1.5) | 1.0–1.1 | 1133 |
 Mean scale of patient education | 1.7 (1.6) | 1.7–1.8 | 1127 |
HIV testinga | |||
 Recommend that all new patients be tested for HIV/AIDS | 53.2% (610) | 50.3–56.1 | 1146 |
 On-site HIV testing (rapid or non-rapid) | 32.3% (370) | 29.5–35.0 | 1147 |